Radioactive Iodine-refractory Differentiated Thyroid Cancer
1 clinical trials · Condition
◉ Watch Radioactive Iodine-refractory Differentiated Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer (NCT04560127) | Peking Union Medical College Hospital | 2020-09-23 |
Track Radioactive Iodine-refractory Differentiated Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.